Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
31 Cards in this Set
- Front
- Back
anemia
|
a manifestation of a pathologic process characterized by a reduction below normal in the number of erythrocytes, quantity of hemoglobin, and/or the volume of packed red cells (hematocrit) in the blood
|
|
aplastic anemia
|
a disease in which the patient has peripheral blood pancytopenia (decrease of all blood cell types) and hypocellular bone marrow
|
|
autologous
|
in transplantation, denotes removal of the patient's own tissue and the giving back of the tissue to that person
|
|
disseminated intravascular coagulation (DIC)
|
a serious bleeding disorder resulting from abnormally initiated and accelerated clotting
|
|
hemachromatosis
|
an autosomal recessive disease characterized by increased intestinal iron absorption and, as a result, increased tissue iron deposition
|
|
hemolytic anemia
|
an anemia caused by destruction of RBCs at a rate that exceeds production
|
|
hemophilia
|
hereditary bleeding disorders caused by defective or deficient clotting factors; classic hemophilia A is a sex-linked recessive genetic disorder caused by deficient factor VIII; hemophilia B is a deficiency of factor IX
|
|
hepatomegaly
|
an abnormal enlargement of the liver
|
|
induction therapy
|
the initial, aggressive stage of cancer treatment that attempts to destroy malignant cells and bring about a remission
|
|
iron-deficiency anemia
|
anemia caused by inadequate iron for hemoglobin production
|
|
leukapharesis
|
a process by which blood is withdrawn from a vein, white blood cells are selectively removed, and the remaining blood is reinfused into the donor
|
|
leukemia
|
general term used to describe a group of malignant disorders affecting the blood and blood-forming tissues of the bone marrow, lymph system, and spleen
|
|
lymphadenopathy
|
enlargement of the lymph nodes or lymph vessels
|
|
lymphoblasts
|
large, immature cells that normally develop into lymphocytes
|
|
lymphocytic leukemia
|
a defect in proliferation and maturation of lymphocytes
|
|
megaloblastic anemias
|
a group of disorders caused by impaired DNA synthesis and characterized by the presence of large red blood cells
|
|
multiple myeloma
|
a condition in which neoplastic plasma cells infiltrate the bone marrow and destroy bone
|
|
myeloblasts
|
large, immature cells that normally develop into granulocytes
|
|
myelodysplastic syndrome
|
a group of related hematologic disorders characterized by a change in the quantity and quality of bone marrow elements
|
|
myelogenous leukemia
|
a defect in proliferation and maturation of granulocytes
|
|
non-Hodgkin's lymphoma
|
a heterogeneous group of malignant neoplasms involving lymphoid tissue
|
|
pernicious anemia
|
a type of megaloblastic anemia resulting from inadequate gastric secretion of intrinsic factor necessary for absorption of cobalamin (vitamin B12)
|
|
Philadelphia chromosome
|
a translocation of the long arm of chromosome 22 to chromosome 9 found in the abnormal myeloblasts, erythroblasts, and megakaryoblasts of 90% of patients with chronic myelogenous leukemia
|
|
polycythemia
|
the production and presence of increased numbers of red blood cells
|
|
sickle cell crisis
|
an exacerbation of sickle cell anemia when sickle cell hemoglobin assumes various crescent or sickle shapes, occluding small blood vessels
|
|
sickle cell disease
|
a group of inherited, autosomal recessive disorders characterized by the presence of an abnormal form of hemoglobin in the erythrocyte
|
|
sickle cell hemoglobin
|
abnormal hemoglobin that causes development of deformed crescent-shaped red blood cells when oxygen tension is lowered
|
|
sickle cell trait
|
a heterozygous state in which an individual has only one sickle cell gene paired with a normal hemoglobin gene
|
|
splenomegaly
|
an abnormal enlargement of the spleen
|
|
thalassemia
|
an autosomal recessive genetic disorder of inadequate production of normal hemoglobin
|
|
thrombocytopenia
|
a reduction of the platelet count below the normal range of 150,000 to 400,000/µl (150 to 400 × 109/L)
|